AR246527A1 - Procedimiento para la preparacion de n-acil-n,n'-di-lisogangliosidos, n'-acil-n,n'-di-lisogangliosidos y n,n'-diacil-n,n'-di-lisogangliosidos. - Google Patents

Procedimiento para la preparacion de n-acil-n,n'-di-lisogangliosidos, n'-acil-n,n'-di-lisogangliosidos y n,n'-diacil-n,n'-di-lisogangliosidos.

Info

Publication number
AR246527A1
AR246527A1 AR90318382A AR31838290A AR246527A1 AR 246527 A1 AR246527 A1 AR 246527A1 AR 90318382 A AR90318382 A AR 90318382A AR 31838290 A AR31838290 A AR 31838290A AR 246527 A1 AR246527 A1 AR 246527A1
Authority
AR
Argentina
Prior art keywords
lisogangliosidos
acil
groups
diacil
aliphatic
Prior art date
Application number
AR90318382A
Other languages
English (en)
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Application granted granted Critical
Publication of AR246527A1 publication Critical patent/AR246527A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00Subject matter not provided for in other groups of this subclass
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

PREPARACION DE N-ACIL-N,N'-DI-LISOGANGLIOSIDOS, N'-ACIL-N,N'-DI- LISOGANGLIOSIDOS Y N,N'-DIACIL-N,N'-DI-LISOGANGLIOSIDOS, DONDE LOS GRUPOS ACILO DERIVAN DE UN ACIDO ORGANICO ALIFATICO, AROMATICO,ARALIFATICO, ALICICLICO O HETEROCICLICO Y EN DONDE UNO DE LOS DOS GRUPOS ACILO NO ES ALIFATICO, ESTERES Y/O AMIDAS DE LOS GRUPOS CARBOXI SIALICOS DE LOS MISMOS, Y/O ESTERES INTERNOS Y/O DERIVADOS PERACILADOS DE LOS MISMOS, QUE COMPRENDE ACILAR N,N'-DI-LISOGANGLIOSIDOS, N-ACIL-N,N'-DI-LISOGANGLIOSIDOS O N'-ACIL- N,N'-DI-LISOGANGLIOSIDOS CON LOS ACIDOS CORRESPONDIENTES O DESACILAR LOS N,N'-DIACIL-N,N'-DI-LISOGANGLIOSIDOS APROPIADOS SELECTIVAMENTE EN EL NITROGENO DE ESFINGOSINA O EN EL NITROGENO NEURAMINICO, O MEZCLAS DE ESTOS COMPUESTOS Y, OPCIONALMENTE CONVERTIR LOS ACIL-DI-LISOGANGLIOSIDOS RESULTANTES EN ESTER, AMIDA, ESTER INTERNO Y/O HIDROXI PERACILADOS.
AR90318382A 1989-11-14 1990-11-14 Procedimiento para la preparacion de n-acil-n,n'-di-lisogangliosidos, n'-acil-n,n'-di-lisogangliosidos y n,n'-diacil-n,n'-di-lisogangliosidos. AR246527A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04855489A IT1238346B (it) 1989-11-14 1989-11-14 Gangliosidi modificati e loro derivati funzionali.

Publications (1)

Publication Number Publication Date
AR246527A1 true AR246527A1 (es) 1994-08-31

Family

ID=11267289

Family Applications (1)

Application Number Title Priority Date Filing Date
AR90318382A AR246527A1 (es) 1989-11-14 1990-11-14 Procedimiento para la preparacion de n-acil-n,n'-di-lisogangliosidos, n'-acil-n,n'-di-lisogangliosidos y n,n'-diacil-n,n'-di-lisogangliosidos.

Country Status (19)

Country Link
US (2) US5264424A (es)
EP (1) EP0433112B1 (es)
JP (1) JPH03170491A (es)
KR (1) KR910009716A (es)
CN (1) CN1033031C (es)
AR (1) AR246527A1 (es)
AT (1) ATE172737T1 (es)
AU (1) AU645766B2 (es)
BR (1) BR9005758A (es)
CA (1) CA2029974A1 (es)
DE (1) DE69032722T2 (es)
ES (1) ES2124214T3 (es)
FI (1) FI905628A0 (es)
HU (1) HU210744B (es)
IL (1) IL96344A0 (es)
IT (1) IT1238346B (es)
NO (1) NO174775C (es)
NZ (1) NZ236057A (es)
PL (1) PL287756A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407072B1 (en) * 1988-12-02 2002-06-18 Fidia S.P.A. Lysoganglioside derivatives
IT1232176B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi
IT1239060B (it) * 1990-05-04 1993-09-20 Fidia Spa Processo per la modulazione selettiva dell'espressione e della funzione di un determinante sulla superficie cellulare attraverso appropriati agenti chimici
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi
US5849717A (en) * 1993-03-04 1998-12-15 Fidia S.P.A. O-sulfated gangliosides and lyso-ganglioside derivatives
IT1267955B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati solfatati dei lisogangliosidi
IT1267956B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati o-solfatati di gangliosidi e lisogangliosidi
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
CZ60499A3 (cs) 1996-09-27 1999-08-11 Guilford Pharmaceuticals Inc. Prostředky s účinkem na NAALADázy, způsoby léčení glutamátové abnormality a způsoby ovlivňování neuronální aktivity u živočichů
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
US7314953B2 (en) 2001-03-27 2008-01-01 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
AU2002326805B2 (en) * 2001-08-29 2009-01-22 Seneb Biosciences, Inc. Novel synthetic ganglioside derivatives and compositions thereof
CA2486303C (en) 2002-05-22 2013-04-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
NZ542148A (en) 2003-03-06 2008-05-30 Neose Technologies Inc Methods and compositions for the enzymatic synthesis of gangliosides
WO2005033700A1 (ja) * 2003-10-03 2005-04-14 Takeda Pharmaceutical Company Limited インスリン抵抗性改善剤のスクリーニング方法
CN1960828B (zh) * 2004-04-15 2011-04-27 密尔沃基电动工具公司 动力工具
WO2006052841A2 (en) * 2004-11-09 2006-05-18 Neose Technologies, Inc. Glycolipids
EP2173166A4 (en) 2007-07-03 2010-08-11 Childrens Hosp & Res Ct Oak POLYSIALIC ACID DE-N-ACETYLASE HEMMER AND METHOD OF USE THEREOF
CA2690440A1 (en) * 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
AU2008272785B2 (en) 2007-07-03 2014-06-12 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
US20120035120A1 (en) 2009-03-25 2012-02-09 Seneb Biosciences, Inc. Glycolipids as treatment for disease
CN109721632B (zh) * 2017-10-27 2023-10-31 齐鲁制药有限公司 一种高纯度神经节苷脂gm1及其制备方法
US20210353659A1 (en) * 2018-08-24 2021-11-18 Industry-Academic Cooperation Foundation, Yonsei University Composition for preventing or treating muscular diseases, or for improving muscular functions, containing gagnlioside

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1046051B (it) * 1975-08-13 1980-06-30 Fidia Spa Nuova applicazione terapeutica dei gangliosidi e procedimento per la loro estrazione
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4716223A (en) * 1981-08-04 1987-12-29 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4593091A (en) * 1981-08-04 1986-06-03 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
IT1235161B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisogangliosidi
IT1232176B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi

Also Published As

Publication number Publication date
ES2124214T3 (es) 1999-02-01
US5424294A (en) 1995-06-13
EP0433112A1 (en) 1991-06-19
CA2029974A1 (en) 1991-05-15
EP0433112B1 (en) 1998-10-28
IL96344A0 (en) 1991-08-16
IT8948554A0 (it) 1989-11-14
NO174775B (no) 1994-03-28
IT1238346B (it) 1993-07-13
CN1033031C (zh) 1996-10-16
KR910009716A (ko) 1991-06-28
NO904921D0 (no) 1990-11-13
BR9005758A (pt) 1991-09-24
JPH03170491A (ja) 1991-07-24
DE69032722T2 (de) 1999-07-08
IT8948554A1 (it) 1991-05-14
CN1051912A (zh) 1991-06-05
NZ236057A (en) 1994-09-27
NO904921L (no) 1991-05-15
HUT55403A (en) 1991-05-28
FI905628A0 (fi) 1990-11-14
PL287756A1 (en) 1991-12-02
AU6662490A (en) 1991-05-23
ATE172737T1 (de) 1998-11-15
DE69032722D1 (de) 1998-12-03
US5264424A (en) 1993-11-23
AU645766B2 (en) 1994-01-27
NO174775C (no) 1994-07-06
HU210744B (en) 1995-07-28

Similar Documents

Publication Publication Date Title
AR246527A1 (es) Procedimiento para la preparacion de n-acil-n,n'-di-lisogangliosidos, n'-acil-n,n'-di-lisogangliosidos y n,n'-diacil-n,n'-di-lisogangliosidos.
US4716175B1 (es)
ES2088655T3 (es) Esteres de l-carnitina y alcanoil l-carnitinas con acido glicolico o sus esteres y composiciones farmaceuticas que las contienen para tratar dermatosis.
ES2124883T3 (es) Compuestos antiviricos.
ITPD910102A1 (it) Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
CO4520281A1 (es) Antifungicos de tetrahidrofurano
NO894888L (no) Esterfremstilling ved hydrogenering av karboksylsyre og anhydrider.
ES2179996T3 (es) Cefalosporinas de vinil-pirrolidinona con sustituyentes basicos.
DE69022678D1 (de) S(+)-Ibuprofen-L-Aminosäure und S(+)-Ibuprofen-D-Aminosäure als Analgetika mit grösserem pharmakologischem Potential.
ES2107707T3 (es) Empleo de esteres de l-carnitina y acil l-carnitina con hidroxiacidos para produccion de composiciones farmaceuticas para el tratamiento de dermatosis.
ES2068555T3 (es) Esteres de glicidilo de aductos de acidos tricarboxilicos.
GR3001523T3 (en) Substituted pyrimidine amides of oleic or linoleic acid as inhibitors of acyl-coa cholesterol acyltransferase
ES8609366A1 (es) Un procedimiento para preparar un derivado de ester de des- glucoteicoplanina
DK314289A (da) Kompositioner
PT88095A (pt) Processo para a preparacao de novos compostos com enxofre e de composicoes farmaceuticas que os contem
FI895765A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten lysogangliosidijohdannaisten valmistamiseksi
PT90813A (pt) Processo de preparacao de derivados da fenotiazina e de composicoes farmaceuticas que os contem
IL92478A0 (en) Sialic acid derivative with active ester groups
ATE145921T1 (de) Esterderivate von antibiotikum-a 40926
ES2083128T3 (es) Procedimiento de obtencion de esteres de arilo por o-desalquilacion y aplicaciones.
DE59006944D1 (de) Verfahren zur Herstellung von 2-Mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren Ester.
TH14007A (th) เอสเทอร์
BR9107157A (pt) Agente de revestimento com alto teor de solidos
IT8703679A0 (it) Sistema per montaggio rapido di armadi stagionali e simili
ITMI952754A1 (it) Ceppi di batteri composizione farmaceutica contenente uno o piu' di tali ceppi ed uso dei medesimi per la prevenzione e la terapia della malattie associate o provocate da un alterato metabolismo degli acidi biliari